Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?

Liver Transplantation

Volumn 13, Issue 6, 2007, Pages 867-874

  Murad, Sarwa Darwish ^a,e   Kim, W Ray ^b   de Groen, Piet C ^b   Kamath, Patrick S ^b   Malinchoc, Michael ^c   Valla, Dominique Charles ^d   Janssen, Harry L A ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c Mayo Clinic   (United States)

^d BEAUJON HOSPITAL   (France)

^e Netherlands Organization for Scientific Research   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; BRAIN DISEASE; BUDD CHIARI SYNDROME; CHRONIC LIVER DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISCRIMINANT ANALYSIS; DISEASE MODEL; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ROC CURVE; SCORING SYSTEM; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 34250667559     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21171     Document Type: Article

References (19)

1. Ludwig J, Hashimoto E, McGill DB, van Heerden JA. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 1990;65:51-55.
2. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364-371.
3. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology 2003;38:793-803.
4. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30:84-89.
5. Murad SD, Valla DC, de Groen PC, Zeitoun G, Hopmans JAM, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39:500-508.
6. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PCJ. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
7. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
8. Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 2005;140:650-654; discussion 655.
9. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KVN, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005;41:353-358.
10. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyoet V, al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005;41:1282-1289.
11. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124: 91-96.
12. van den Besselaar AM. Precision and accuracy of the international normalized ratio in oral anticoagulant control. Haemostasis 1996;26(suppl 4):248-265.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
14. Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Boschet J, al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004;40: 1197-1202.
15. Perello A, Garcia-Pagan JC, Gilabert R, Suárez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002;35:132-139.
16. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003;52:879-885.
17. Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003;98:1167-1174.
18. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003;52:134-139.
19. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903.